Navidea Biopharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch NAVB and buy or sell other stocks, ETFs, and their options commission-free!

About NAVB

Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutic. It operates through the following segments: Diagnostics, Therapeutics, and Corporate. 

CEO
Michael S. Rosol, PhD
CEOMichael S. Rosol, PhD
Employees
Employees
Headquarters
Columbus, Ohio
HeadquartersColumbus, Ohio
Founded
1983
Founded1983
Employees
Employees

NAVB Key Statistics

Market cap
10.00K
Market cap10.00K
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
1.79K
Average volume1.79K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$0.0431
52 Week high$0.0431
52 Week low
52 Week low

Stock Snapshot

Navidea Biopharmaceuticals(NAVB) stock is priced at $1.61, giving the company a market capitalization of 10K.

Navidea Biopharmaceuticals(NAVB) stock opened on 2026-05-21 at —. The price climbed to — and dipped to —.

Navidea Biopharmaceuticals(NAVB) shares are trading with a volume of 0, against a daily average of 1.79K.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.